NCT02226315

Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies

A Retrospective Analysis of Fetal Outcome Compared to Massively Parallel Sequencing Test Results Obtained From Multiple Gestation Pregnancies at Increased Risk for Fetal Chromosomal Aneuploidy

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 50 (actual)
• Sponsor: Sequenom, Inc. · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the clinical performance of massively parallel sequencing (MPS) using the MaterniT21 PLUS LDT in the detection of fetal aneuploidy in circulating cfDNA extracted from a maternal blood sample obtained from women pregnant with a multiple gestation who were at increased risk for fetal aneuploidy.

Conditions

• Down Syndrome
• Edwards Syndrome
• Patau Syndrome
• Turner Syndrome

Timeline

• Start date: 2014-08-01
• Primary completion: 2015-09-01
• Completion: 2015-09-01
• First posted: 2014-08-27
• Last updated: 2015-09-17

Locations

1 site across 1 country: United States